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Abstract
Efficacy of extracorporeal shock wave therapy (ESWT) in the treatment of plantar fasciitis (PF) is under debate in spite of applying in treatment. We 
aimed to investigate the efficacy of extracorporeal shock wave therapy in decreasing plantar fasciitis heel pain.
Methods: Eighty patients fulfilled the inclusion criteria; 77 agreed to participate the study. Patients randomly divided into 2 groups of treating with NSAID 
alone and NSAID+ESWT and assessed in to periods of 4 and 8 weeks with a focus on ESWT effectiveness.
Results: Visual analog score decreased significantly after eight weeks of treatment with ESWT+NSAID in comparison with NSAID group alone. (p<0.05)
Conclusion: ESWT reduced pain of PF in our study. So it could be used as treatment options.
INTRODUCTION 
Plantar fasciitis (PF) is one of the most common causes of 
heel pain in adults, while its etiology is not clear. Although some 
risk factors have been suggested including those conditions that 
increase the pressure at the sole such as prolonged standing 
position, obesity, flat foot, and repetitive trauma to the sole [1-4]. 
The diagnosis of plantar fasciitis is based on plantar point 
tenderness as the hallmark and morning sole pain gradually 
relieving with walking [5] However, radiographic studies are 
required to rule out other conditions. Ultrasonography of the 
foot is also useful in diagnosis and follow-ups demonstrating 
thickening of plantar fascia, decreased echogenicity at the 
insertion of plantar fascia upon the calcaneus, and features of 
edema between the fascia and surrounding tissues [5,6].
The treatment options for relieving PF symptoms include 
activity modification, plantar fascia stretching, ice massage, night 
splints, non-steroidal anti-inflammatory drugs, local steroid 
injections, extracorporeal shockwave therapy, and surgery [3].
Extracorporeal shock wave therapy (ESWT) has been widely 
used as a suitable treatment option for musculoskeletal disorders 
such as tendinopathies and bone healing disturbances [16]. In 
addition it has been used for plantar fasciitis treatment due to 
its convenience, noninvasive nature and fast recovery time [5,6]. 
The specific mechanisms of ESWT in treating musculoskeletal 
pain is not clear; multiple studies have reported that it can 
destroy sensory unmyelinated nerve fibers, and stimulate 
neovascularization and collagen synthesis in degenerative 
tissues [3,7,8].
In this study we conducted a randomized trial to evaluate the 
efficacy of ESWT in the management of plantar fasciitis.
METHODS
This randomized clinical trial was registered in the research 
and ethics committee of Ardabil University of medical sciences. 
Inclusion criteria included at least three months heel pain 
compatible with PF pattern without any history of diabetes, 
rheumatologic disease, arthritis, neurological abnormalities, 
recent trauma or foot surgery, infectious diseases, and 
malignancy. Based on the criteria, 80 patients entered the study 
and grouped in 2 clusters; first group received NSAID (Naproxen 
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tablet 500 mg every 12 hr) as well as 5 sessions shockwave 
therapy and second group received Naproxen only as mentioned. 
In the meantime, conservative managements including stretching 
exercises were applied for both groups.
Shockwave intervention was carried out for 5 sessions with 
a 72-hours interval by the same operator using a 12 MHz linear 
array transducer. For each session a pressure of 2 bars with 2000 
shockwaves were applied.
Self report pain score (Visual Analog Score) was recorded 
before the study and at 4th and 8th weeks after treatment.
Statistical analysis 
Data were analyzed with SPSS software for windows, version 
16.0 (SPSS Inc., Chicago IL., and USA). A paired samples t-test, 
independent t-test and ANOVAs were applied for the analysis. 
A result was considered to be statistically significant with (P 
value<0.05.)
RESULTS
 Two patients from first group and 1 patient from second group 
refused to continue the study. Seventy-seven patients including 
41 females and 36 males suffering plantar fasciitis agreed to 
participate the study (Figure 1). Mean age of participants was 
49.51 years and mean body mass index was 26.82.Demographic 
characteristics of the both groups are outlined in Table 1. There 
was no significant difference between the two groups in terms 
of baseline characteristics. Pain improvement was seen in both 
groups but with significance in ECWT group especially after eight 
weeks, as shown in detail in table 2.
DISCUSSION
Multiple treatment options has been proposed for plantar 
fasciitis, including activity modification, stretching plantar 
fascia, ice massage, night splints, nonsteroidal anti-inflammatory 
drugs combined with other treatment modalities, local steroid 
injections, extracorporeal shockwave therapy, and surgery [3]. 
Effectiveness of some of them especially ESWT are not clearly 
described. Recently the use of ESWT approved by the FDA for 
treatment of plantar fasciitis in the USA [9]. The current study 
conducted for evaluating the efficacy of the ESWT in Iran.
Haake et al. previously reported better improvement in the 
ESWT treatment than the placebo group [7].
In another study, Rompe et al. indicated stretching exercise 
and low energy shock wave therapy together improved patients’ 
symptoms more in comparison with the stretching alone [10]. 
Some other studies reported mostly effectiveness of ESWT 
in pain subsidence of heel pain and plantar fasciitis in spite of 
different significances [11-15].
On the other hand, Speed et al. reported no beneficial effects 
for shock wave therapy for PF [8].
These different results for the efficacy of ESWT in plantar 
fasciitis may be due to multiple factors ,like study populations, 
heterogeneity of treatment parameters such as shock wave 
intensity, geometry of the shock wave focus, focal energy, 
different placebos and patients’ self treatments.
In our population study in Iranian northwest, use of ESWT 
after 4 and 8weeks resulted in significant symptom relief and 
patients’ satisfaction in comparison with the use of NSAID only.
CONCLUSION
So that is clinically recommended that applying ESWT would 
be helpful for patients suffering PF.
Further studies, especially in Iranian population, are also 
proposed with larger study groups to better investigate the 
efficacy of the treatment.
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Table 1: Demographic characteristics of the case and control groups.
P value NSAID ESWT+NSAID
0.4 50.95±9.86 48.07±10.74 age
0.5 19/20 22/16 Sex (F/M)
0.52 26.8/26.9 27.1/26 Body Mass Index (F/M)
Table 2:  Pain improvement in both groups based on average VAS.






3.2 3.69 7.37 ESWT+NSAID
3.65 4.37 7.2 NSAID
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